Clinical and paraclinical particularities of renal involvement in SARS-COV-2 infection

Authors

Keywords:

COVID-19, SARS-CoV2, kidney damage

Abstract

COVID-19 is a respiratory disease caused by a novel coronavirus with serious multisystem complications. The purpose of publication is highlighting the clinical characteristics of patients with SARS-CoV2 with or without renal pathology. A retrospective and descriptive study of 60 patients (average age 57.02 years) with the new type Coronavirus (COVID-19) infection. The patients were selected from the Nephrology department of Timofei Moșneaga Republican Clinical Hospital hospitalized between March 2021 and August 2022. The clinical, paraclinical and treatment data were examined. Distribution by age: men 40-59 years – 12 (40%), 18-39 years – 2 (6.66%); women between the ages of 40-59 and corresponds to men, but the rarest – after the age of 70 5 (16.6 %). In women – tubule-interstitial nephropathy - 8 (26.6%), glomerular nephropathy - 3 (10%), kidney stones - 6 (20%); from men – tubule-interstitial nephropathies - 3 (10%), glomerular nephropathies - 4 (13.3%), kidney stones - 9 (30%). Fatal cases were found in the following age groups: 40-59 years – 4 men (13.3%) and 5 women (16.6%), between 60-69 years – 3 men (10%) and 1 woman (3.33%); >70 years – 5 men (16.6%) and 4 women (13.3%). Renal damage was quite frequent in severe pneumonia with COVID-19, which was associated with typical complications, which was associated with mortality in the presence of risk factors. These are advanced age, metabolic syndrome, arterial hypertension. Kidney damage was quite common in severe pneumonia with COVID-19, which was associated with typical complications, and higher mortality, especially in the presence of risk factors, among which were advanced age, metabolic syndrome, arterial hypertension.

References

1. Johns Hopkins Coronavirus Resource Center COVID-19 Map. [(accessed on 6 March 2021)]; Available online: https://coronavirus.jhu.edu/map.html

2. Jordan R.E., Adab P., Cheng K.K. Covid-19: Risk factors for severe disease and death. BMJ. 2020;368:m1198. https://doi.org/10.1136/bmj.m1198

3. Pei G., Zhang Z., Peng J., Liu L., Zhang C., Yu C., Ma Z., Huang Y., Liu W., Yao Y., et al. Renal involvement and early prognosis in patients with COVID-19 pneumonia. J. Am. Soc. Nephrol. 2020;31:1157-1165. https://doi.org/10.1681/ASN.2020030276

4. Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X., Liu L., Shan H., Lei C.L., Hui D.S., et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N. Engl. J. Med. 2020;382:1708-1720. https://doi.org/10.1056/NEJMoa2002032

5. Pan X.W., Xu D., Zhang H., Zhou W., Wang L.H., Cui X.G. Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: A study based on single-cell transcriptome analysis. Intensive Care Med. 2020;46:1114-1116. https://doi.org/10.1007/s00134-020-06026-1

6. Silver S.A., Beaubien-Souligny W., Shah P.S., Harel S., Blum D., Kishibe T., Meraz-Munoz A., Wald R., Harel Z. The Prevalence of Acute Kidney Injury in Patients Hospitalized With COVID-19 Infection: A Systematic Review and Meta-analysis. Kidney Med. 2021;3:83-98.e1. https://doi.org/10.1016/j.xkme.2020.11.008

7. Li Z., Wu M., Yao J., Guo J., Liao X., Song S., Li J., Duan G., Zhou Y., Wu X., et al. Caution on Kidney Dysfunctions of COVID-19 Patients. MedRxiv. 2020 https://doi.org/10.1101/2020.02.08.20021212

8. Xu S., Fu L., Fei J., Xiang H.X., Xiang Y., Tan Z.X., Li M.D., Liu F.F., Li Y., Han M.F., et al. Acute kidney injury at early stage as a negative prognostic indicator of patients with COVID-19: A hospital- based retrospective analysis. MedRxiv. 2020 https://doi.org/10.1101/2020.03.24.20042408

9. Xu J., Xie J., Du B., Tong Z., Qiu H., Bagshaw S.M. Clinical Characteristics and Outcomes of Patients with Severe COVID-19 Induced Acute Kidney Injury. J. Intensive Care Med. 2021;36:319-326. https://doi.org/10.1177/0885066620970858

10. Khwaja A. KDIGO Clinical Practice Guidelines for Acute Kidney Injury. Nephron. Clin. Pract. 2012;120:c179-c184. https://doi.org/10.1159/000339789

11. Al-Khafaji A., Nadim M.K., Kellum J.A. Hepatorenal disorders. Chest. 2015;148:550-558. https://doi.org/10.1378/chest.14-1925

12. Martinez-Rojas M.A., Vega-Vega O., Bobadilla N.A. Is the kidney a target of SARS-CoV-2? Am. J. Physiol. Ren. Physiol. 2020;318:F1454-F1462. https://doi.org/10.1152/ajprenal.00160.2020

13. Batlle D., Soler M.J., Sparks M.A., Hiremath S., South A.M., Welling P.A., Swaminathan S. Acute kidney injury in COVID-19: Emerging evidence of a distinct pathophysiology. J. Am. Soc. Nephrol. 2020;31:1380-1383. https://doi.org/10.1681/ASN.2020040419

14. Velez J.C.Q., Caza T., Larsen C.P. COVAN Is the New HIVAN: The Re-Emergence of Collapsing Glomerulopathy with COVID-19. Nat. Rev. Nephrol. 2020;16:565-567. https://doi.org/10.1038/s41581-020-0332-3

15. Gabarre P., Dumas G., Dupont T., Darmon M., Azoulay E., Zafrani L. Acute kidney injury in critically ill patients with COVID-19. Intensive Care Med. 2020;46:1339e48. https://doi.org/10.1007/s00134-020-06153-9

16. Nasr S.H., Kopp J.B. COVID-19−associated collapsing glomerulopathy: An emerging entity. Kidney Int. Rep. 2020;5:759-761.

https://doi.org/10.1016/j.ekir.2020.04.030

17. Peleg Y., Kudose S., D'Agati V., Siddall E., Ahmad S., Nickolas T., Kisselev S., Gharavi A., Canetta P. Acute kidney injury due to collapsing glomerulopathy following COVID-19 infection. Kidney Int. Rep. 2020;5:940-945. https://doi.org/10.1016/j.ekir.2020.04.017

18. Post A., den Deurwaarder E.S.G., Bakker S.J.L., de Haas R.J., van Meurs M., Gansevoort R.T., Berger S.P. Kidney Infarction in Patients With COVID-19. Am. J. Kidney Dis. 2020;76:431-435. https://doi.org/10.1053/j.ajkd.2020.05.004

19. Gustine J.N., Jones D. Immunopathology of Hyperinflammation in COVID-19. Am. J. Pathol. 2021;191:4-17. https://doi.org/10.1016/j.ajpath.2020.08.009

20. Sundaram S., Soni M., Annigeri R. Urine abnormalities predict acute kidney injury in COVID-19 patients: An analysis of 110 cases in Chennai, South India. Diabetes Metab. Syndr. 2021;15:187-191. https://doi.org/10.1016/j.dsx.2020.12.021

21. Ruan Q., Yang K., Wang W., Jiang L., Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46:846-848. https://doi.org/10.1007/s00134-020-05991-x

22. GROPPA, Liliana, AGACHI, Svetlana, SASU, Boris, et al. Afectarea renală în maladia COVID-19: sinteză de literature. Kidney involvement in COVID-19 disease: review article. In: Revista de Ştiinţe ale Sănătăţii din Moldova. 2020, vol. 24(2), pp. 4-16. ISSN 2345-1467

Published

2026-05-03

How to Cite

[1]
Bondari, N. et al. 2026. Clinical and paraclinical particularities of renal involvement in SARS-COV-2 infection. Public Health Economy and Management in Medicine. 2(93) (May 2026), 237–241.

Most read articles by the same author(s)

Similar Articles

1-10 of 119

You may also start an advanced similarity search for this article.